Effects of vitamin D-fortified low fat yogurt on glycemic status, anthropometric indexes, inflammation, and bone turnover in diabetic postmenopausal women: A randomised controlled clinical trial

Clinical Nutrition

Volumn 35, Issue 1, 2016, Pages 67-76

  Jafari, Tina ^a   Faghihimani, Elham ^b   Feizi, Awat ^c   Iraj, Bijan ^b   Javanmard, Shaghayegh Haghjooy ^d   Esmaillzadeh, Ahmad ^a   Fallah, Aziz A ^e   Askari, Gholamreza ^a  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e SHAHREKORD UNIVERSITY   (Iran)

Author keywords

Bone turnover; Glycemic status; Inflammation; Low fat yogurt; Type 2 diabetes mellitus; Vitamin D fortification

Indexed keywords

25 HYDROXYVITAMIN D; BIOLOGICAL MARKER; GLUCOSE; HEMOGLOBIN A1C; INSULIN; OMENTIN; UNCLASSIFIED DRUG; VITAMIN D; YOGHURT; CYTOKINE; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ITLN1 PROTEIN, HUMAN; LECTIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ANTHROPOMETRY; ARTICLE; BODY MASS; BODY WEIGHT; BONE TURNOVER; CONTROLLED STUDY; DIET RESTRICTION; DOUBLE BLIND PROCEDURE; FAT MASS; FEMALE; FOOD INTAKE; FORTIFIED FOOD; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; INFLAMMATION; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PARALLEL DESIGN; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIAL; WAIST CIRCUMFERENCE; WAIST HIP RATIO; BLOOD; BONE REMODELING; DIET THERAPY; EXERCISE; METABOLISM; MIDDLE AGED; MULTIVARIATE ANALYSIS; NUTRITIONAL ASSESSMENT; QUESTIONNAIRE; RECALL; SUNLIGHT;

BIOMARKERS; BLOOD GLUCOSE; BODY MASS INDEX; BONE REMODELING; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CYTOKINES; DIABETES MELLITUS, TYPE 2; DOUBLE-BLIND METHOD; EXERCISE; FASTING; FEMALE; FOOD, FORTIFIED; GPI-LINKED PROTEINS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INFLAMMATION; INSULIN; LECTINS; MENTAL RECALL; MIDDLE AGED; MULTIVARIATE ANALYSIS; NUTRITION ASSESSMENT; POSTMENOPAUSE; SUNLIGHT; SURVEYS AND QUESTIONNAIRES; TRIGLYCERIDES; VITAMIN D; YOGURT;

EID: 84924912010     PISSN: 02615614     EISSN: 15321983     Source Type: Journal    
DOI: 10.1016/j.clnu.2015.02.014     Document Type: Article

References (34)

1. International Diabetes Federation Diabetes: facts and figures 2014, IDF, [accessed 8.7.14], at. http://www.idf.org/worlddiabetesday/toolkit/gp/facts-figures.
2. Jafari T., Fallah A.A., Azadbakht L. Role of dietary n-3 polyunsaturated fatty acids in type 2 diabetes: a review of epidemiological and clinical studies. Maturitas 2013, 74:303-308.
3. González-Molero I., Rojo-Martínez G., Morcillo S., Gutiérrez-Repiso C., Rubio-Martín E., Almaraz M.C., et al. Vitamin D and incidence of diabetes: a prospective cohort study. Clin Nutr 2012, 31:571-573.
4. Sugden J.A., Davies J.I., Witham M.D., Morris A.D., Struthers A.D. Vitamin D improves endothelial function in patients with type 2 diabetes mellitus and low vitamin D levels. Diabet Med 2008, 25:320-325.
5. Holick M.F., Binkley N.C., Bischoff-Ferrari H.A., Gordon C.M., Hanley D.A., Heaney R.P., et al. Evaluation, treatment, and prevention of vitamin D deficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2011, 96:1911-1930.
6. O'Mahony L., Stepien M., Gibney M.J., Nugent A.P., Brennan L. The potential role of vitamin D enhanced foods in improving vitamin D status. Nutrients 2011, 3:1023-1041.
7. IOM (Institute of Medicine) Dietary reference intakes for calcium and vitamin D 2011, The National Academies Press, Washington DC.
8. Heshmat R., Mohammad K., Majdzadeh S.R., Forouzanfar M.H., Bahrami A., Omrani G.R., et al. Vitamin D deficiency in Iran: a multi-center study among different urban areas. Iran J Publ Health 2008, 37:72-78.
9. Shab-Bidar S., Neyestani T.R., Djazayery A., Eshraghia M.R., Houshiarrad A., Gharavi A.A., et al. Regular consumption of vitamin D-fortified yogurt drink (Doogh) improved endothelial biomarkers in subjects with type 2 diabetes: a randomized double-blind clinical trial. BMC Med 2011, 9:125-135.
10. Neyestani T.R., Hajifaraji M., Omidvar N., Nikooyeh B., Eshraghian M.R., Shariatzadeh N., et al. Calcium-vitamin D-fortified milk is as effective on circulating bone biomarkers as fortified juice and supplement but has less acceptance: a randomised controlled school-based trial. J Hum Nutr Diet 2014, 27:606-616.
11. 1 produces a favorable bone biomarker profile supporting healthy bone metabolism in postmenopausal women with metabolic syndrome. Nutr Res 2011, 31:347-355.
12. World Health Organization Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: report of a WHO/IDF consultation 2006, World Health Organization, Geneva.
13. Franz M.J., Bantle J.P., Beebe C.A., Brunzell J.D., Chiasson J.L., Garg A., et al. Nutrition principles and recommendations in diabetes. Diabetes Care 2004, 27:S36-S46.
14. George P.S., Pearson E.R., Witham M.D. Effect of vitamin D supplementation on glycaemic control and insulin resistance: a systematic review and meta-analysis. Diabet Med 2012, 29:e142-e150.
15. Ainsworth B.E., Haskell W.L., Herrmann S.D., Meckes N., Bassett D.R., Tudor-Locke C., et al. 2011 compendium of physical activities: a second update of codes and MET values. Med Sci Sports Exerc 2011, 43:1575-1581.
16. Song Y., Wang L., Pittas A.G., Del Gobbo L.C., Zhang C., Manson J.E., et al. Blood 25-hydroxy vitamin D levels and incident type 2 diabetes: a meta-analysis of prospective studies. Diabetes Care 2013, 36:1422-1428.
17. Danescu L.G., Levy S., Levy J. Vitamin D and diabetes mellitus. Endocrinol 2009, 35:11-17.
18. Ojuka E.O. Role of calcium and AMP kinase in the regulation of mitochondrial biogenesis and GLUT4 levels in muscle. Proc Nutr Soc 2004, 63:275-278.
19. Alkharfy K.M., Al-Daghri N.M., Sabico S.B., Al-Othman A., Moharram O., Alokail M.S., et al. Vitamin D supplementation in patients with diabetes mellitus type 2 on different therapeutic regimens: a one-year prospective study. Cardiovasc Diabetol 2013, 12:113.
20. Heikkinen A.M., Tuppurainen M.T., Niskanen L., Komulainen M., Penttila I., Saarikoski S. Long-term vitamin D3 supplementation may have adverse effects on serum lipids during postmenopausal hormone replacement therapy. Eur J Endocrinol 1997, 137:495-502.
21. Caan B., Neuhouser M., Aragaki A., Lewis C.B., Jackson R., LeBoff M.S., et al. Calcium plus vitamin D supplementation and the risk of postmenopausal weight gain. Arch Intern Med 2007, 167:893-902.
22. LeBlanc E.S., Rizzo J.H., Pedula K.L., Ensrud K.E., Cauley J., Hochberg M., et al. Associations between 25-Hydroxyvitamin D and weight gain in elderly women. J Womens Health 2012, 21:1066-1073.
23. McCarty M.F., Thomas C.A. PTH excess may promote weight gain by impeding catecholamine-induced lipolysis implications for the impact of calcium, vitamin D, and alcohol on body weight. Med Hypotheses 2003, 61:535-542.
24. Wood R.J. Vitamin D and adipogenesis: new molecular insights. Nutr Rev 2008, 66:40-46.
25. Nikooyeh B., Neyestani T.R., Farvid M., Alavi-Majd H., Houshiarrad A., Kalayi A., et al. Daily consumption of vitamin D- or vitaminD-calcium-fortified yogurt drink improved glycemic control in patients with type 2 diabetes: a randomized clinical trial. Am J Clin Nutr 2011, 93:764-771.
26. Witham M.D., Nadir M.A., Struthers A.D. Effect of vitamin D on blood pressure: a systematic review and meta-analysis. J Hypertens 2009, 27:1948-1954.
27. Nagpal S., Na S., Rathnachalam R. Noncalcemic actions of vitamin D receptor ligands. Endocr Rev 2005, 26:662-687.
28. Bellia A., Garcovich C., D'Adamo M., Lombardo M., Tesauro M., Donadel G., et al. Serum 25-hydroxyvitamin D levels are inversely associated with systemic inflammation in severe obese subjects. Intern Emerg Med 2013, 8:33-40.
29. Autier P., Boniol M., Pizot C., Mullie P. Vitamin D status and ill health: a systematic review. Lancet Diabetes Endocrinol 2014, 2:76-89.
30. Van den Berghe G., Van Roosbroeck D., Vanhove P., Wouters P.J., De Pourcq L., Bouillon R. Bone turnover in prolonged critical illness: effect of vitamin D. J Clin Endocrinol Metab 2003, 88:4623-4632.
31. Yang R.Z., Lee M.J., Hu H., Pray J., Wu H.B., Hansen B.C., et al. Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action. Am J Physiol-Endocrinol Metab 2006, 290:E1253-E1261.
32. Pan H.Y., Guo L., Li Q. Changes of serum omentin-1 levels in normal subjects and in patients with impaired glucose regulation and with newly diagnosed and untreated type 2 diabetes. Diabetes Res Clin Pract 2010, 88:29-33.
33. Wang D., Jiang T.J., Liao L., Huang J. Relationships between serum omentin-1 concentration and bone mineral density, and bone biochemical markers in Chinese women. Clin Chim Acta 2013, 426:64-67.
34. Brown J.P., Albert C., Nassar B.A., Adachi J.D., Cole D., Davison K.S., et al. Bone turnover markers in the management of postmenopausal osteoporosis. Clin Biochem 2009, 42:929-942.